New Zealand is a rich source of food components that may have bioactivity on bone. Docosahexaenoic acid (DHA) from fish oil has been shown to maintain bone in ovariectomised (OVX) rats. Kiwifruit, a source of fibre and carotenoids 2 may also affect bone via a prebiotic as well as direct cell based mechanisms.
Introduction
Osteoporosis is a critical disorder involving bone loss due to estrogen deficiency in postmenopausal women. With the loss of estrogen, bone turnover increases while being uncoupled from the process of formation and the result is a net loss of bone. Hormone replacement therapy is most effective for the prevention of postmenopausal osteoporosis (1), however, hormone replacement therapy can cause adverse effects such as the development of hormone-dependent breast and uterine cancers (2) . Soybean isoflavones have similar structures to those of estrogen and have a weak affinity for the estrogen receptors, specifically estrogen receptor β which is predominant in bone, brain, thymus, bladder and prostate (3) . Genistein, one of the isoflavones, has been reported to have inhibitory effects on bone resorption in vitro, similar to estrogen which is known for suppressing bone resorption activity (4) . We also demonstrated that soy isoflavones, such as daidzein, genistein, and equol, suppressed osteoclast formation in vitro (5) . A recent meta-analysis indicates that isoflavone interventions significantly attenuate bone loss in postmenopausal women (6) . In addition, the risk for adverse effects of isoflavone treatment appears to be lower than that of hormone replacement therapy (7) . Therefore, intake of soybean isoflavones can be considered as one of the alternative agents to hormone replacement therapy and further research on prevention of bone loss or maintenance of bone health in menopausal women is required. .
Daidzein is metabolized to equol in the intestine by gut microflora and equol possesses a stronger estrogenic activity than daidzein (8) . For example, equol administration inhibited femoral bone loss in ovariectomized (OVX) mice without estrogenic activity in the reproductive organs (9) . Furthermore, we also demonstrated that intake of equol-containing soy fermented food inhibited bone resorption in postmenopausal women not producing equol (10) . Therefore, the clinical effectiveness of isoflavones, especially daidzein, is due the further metabolism in the gut producing equol. The latter depends on various factors including the microbiota diversity in the large intestine as well as diet and ethnicity. In humans, only 30-50% of the population can produce equol (11) (12) (13) .
Recent animal studies indicate that gut bacteria can be manipulated to modify the metabolism of isoflavones in the intestine. Fructooligosaccharides (FOS) increase the bioavailability of isoflavones, leading to cooperative effects in the prevention of bone loss in OVX mice (14) . Also, polydextrose and raffinose stimulate equol production, and enhance the bone-protective effects of daidzein in OVX mice (15) . A small cross-over study in Japanese women supplemented women with 37mg isoflavones plus/ minus 5g FOS per day for 2 weeks but observed no effect of the prebiotic on metabolism of daidzein (16) . Lampe et al. reported that dietary fibre may promote the growth and/or the activity of bacterial populations responsible for equol production (17) . Thus, several 6 studies have examined the dietary fibre has been associated with ability of equol production.
The purpose of our research programme was to 1) investigate whether kiwifruit or omega 3 fatty acids have specific modulatory effects on bone cells in vitro, and to 2) investigate whether the metabolism of the isoflavones could be affected by selected foods including kiwifruit and omega 3 fatty acids.
Kiwifruit
Kiwifruit contain several components that may have bioactivity in bone. These include amongst others calcium (20-34mg/100g) and magnesium, as well as vitamins such as vitamin C (93-105mg/100g), vitamin K (0.006 -0.04mg/100g) as well as dietary fibre (18) .
A study in Caco-2 cell monolayers where the cells were pretreated with aqueous kiwifruit extracts, showed that gold kiwifruit extract significantly improved calcium uptake (18 ) with green kiwifruit having no effect. In an animal 7 feeding study using pigs aged 28 days, the animals were fed fresh kiwifruit at 15g of fruit/kg of body weight/day for 4 weeks. In this study green as well as gold kiwifruit improved calcium retention significantly in comparison to an ascorbic acid fed control group (18) . This study indicated that vitamin C could affect mineral uptake. Vitamin C is also essential for the formation of collagen and the synthesis of hydroxyproline and few studies report a relationship between vitamin C and bone density (BMD) (19) . Other factors present in kiwifruit may also affect mineral metabolism such as the carotenoids.
Epidemiological reports have shown an inverse relationship between carotenoid intake and low BMD, risk of fracture and risk for developing osteoporosis (20) .
An older in vitro study suggested that carotenoids may inhibit osteoclast formation and therefore be bone protective. A recent study beta-carotene, lutein as well as zeaxanthin suppressed osteoclast formation (5).
There is a significant amount of vitamin K in green kiwifruit specifically, up to 8 60% of the RDI. The requirement of sufficient vitamin K in the diet to support bone health has been documented well over the past years (21) . Osteocalcin is a vitamin K dependent protein produced by osteoblasts during bone formation and is the primary noncollageneous protein in bone. Osteocalcin functions as a regulator of bone mineral maturation (21) . The γ-carboxylation of osteocalcin is the primary mechanism underlying the hypothesized protective influence of vitamin K on bone. Vitamin K can also modulate certain cytokines involved in bone turnover, such as osteoprotegerin and interleukin-6 (21), which may be an additional mechanism by which vitamin K influences bone turnover. Kiwifruit is also rich source of dietary fibre (22) , and has been shown to have a prebiotic effect of promoting the content of faecal lactobacilli and bifidobacteria in healthy female adults (23) . Furthermore, Han et al. reported that inclusion of kiwifruit fibre in diets modulated the colonic bacterial community in pigs (24) . In a rat study we reported synergistic effects of daidzein and kiwifruit on bone in 9 ovariectomised (OVX) rats (25) . The results showed that the combination of daidzein with green kiwifruit reduced ovariectomy-induced decline in bone mineral density (BMD) compared to the OVX control rats, but kiwifruit did not affect equol production in the rats. In a further study we investigated the effects of green and gold kiwifruit in the absence of daidzein on bone loss, bone markers and molecular markers for bone formation/ resorption in OVX mice. The preliminary data obtained from a rat study (25) and the mouse study as described above, prompted further investigation of an effect by green kiwifruit in menopausal women. In a cross-over design, we supplemented women aged between 50 and 65 with 50 mg isoflavones daily from an oral supplement ('Nature Made Soy Isoflavone', Otsuka Pharmaceutical Ltd., Tokyo, Japan) containing daidzein and genistein in an unknown ratio. Of the total isoflavone dose 47.2 mg were aglycone and 2.8 mg were glycosidic. They were taking the supplement for two series of six weeks separated by a washout of two weeks, with our without two fresh green kiwifruit per day. Blood, urine and faecal samples were collected at various time points and analysed for microflora diversity, equol production, blood lipid levels and bone turnover markers.
Preliminary data indicate that the green kiwifruit in combination with the isoflavones were bone protective ; unpublished data).
Omega 3 fatty acids
There is a substantial body of evidence that has accumulated over the past year that dietary long chain polyunsaturated fatty acids (LCPUFAs) with a chain length longer than 18C, are beneficial for bone health. Research over the past 20 years have suggested that PUFAs of the n-3 series, as well as the n-6 fatty acid gamma linolenic acid (GLA), may prove beneficial to bone health when consumed in appropriate amounts (26) . In addition, it has been shown that a reduction of the n-6/n-3 PUFA ratio could result in increased bone strength in animals and reduce bone loss in humans (27 -29) .
PUFAs are divided into two classes according to their structure. The longer chain PUFAs can originate from the dietary 18-carbon precursors α-linolenic (ALA,18:3n-3) and linoleic acids (LA,18:2n-6) respectively and these are considered to be essential fatty acids as they cannot be synthesised by human tissue (29) . Through a process of desaturation and elongation, the longer chain 
Conclusion
Long chain fatty acids have significant effects on reducing osteoclastogenesis and disrupting function of the osteoclast and daidzein and genistein enhanced the effects. Green kiwifruit modulate molecular markers of bone resorption and in older women may be bone protective.
